Stocks

F&O

Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space

Indices

Track markets across the globe

Terminal

Track charts, orders, positions, watchlists in one place

Option chain

Analyse chains, view payoffs, create baskets

Pledge

Get extra balance for trading

Commodities

Trade in Crude Oil, Gold, Silver and more

API trading

Set up and execute trades through our API

Mutual Funds

Invest in Mutual Funds

Invest in direct mutual funds at zero charges via lump sump investments or SIPs

Mutual Fund Houses

Know about AMCs, funds, fund managers

NFO’s

Track all active NFOs in one place

Mutual Funds by Groww

Mutual funds by Groww designed for your investment goals

Start SIP

Build long-term wealth through disciplined monthly investing.

Mutual Funds screener

Filter funds based on risk, fund size and more

Track Funds

Import funds and track all investments in a single place

Compare Funds

SIP calculator

Estimate returns on a SIP

Brokerage calculator

Estimate charges for your trade/investment

Margin calculator

Estimate balance needed to buy/sell a stock

SWP calculator

Returns on your systematic withdrawal plan

Pricing

Brokerage and charges on Groww

Blog

Credit

Loan against securities and Personal loan

AARTIPHARM •NSE

Aarti Pharmalabs Ltd.

₹669.25-3.45 (0.51%)1D

All

Terminal

Create Stock SIPAutomate your investments in this

Overview

Technicals

News

Events

Performance

Today’s low

654.00

Today’s high

677.85

52 week low

585.00

52 week high

969.50

Open price

669.00

Previous close

672.70

Live volume

1,54,918

Lower circuit

538.20

Upper circuit

807.20

Fundamentals

Market Cap

₹6,106Cr

ROE

8.22%

P/E Ratio(TTM)

34.94

EPS(TTM)

19.27

P/B Ratio

2.87

Dividend Yield

0.52%

Industry P/E

36.67

Book Value

234.30

Debt to Equity

0.36

Face Value

Financial performance

Quarterly

Yearly

All Financials

MAR '26

Revenue (Cr)

₹591

+36.77%

Profit (Cr)

₹61.12

+27.44%

0150300450600

Mar '25

Jun '25

Sep '25

Dec '25

Mar '26

Revenue growth	Value
1Y (TTM)	+5%
3Y CAGR	+21%

Profit growth	Value
1Y (TTM)	-31%
3Y CAGR	+31%

About

Aarti Pharmalabs Limited manufactures active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives.;

CEO/MD

Nikhil Gogri

Founded in

2019

NSE symbol

AARTIPHARM

Shareholding Pattern

Jun '26

Mar '26

Dec '25

Sep '25

Jun '25

Promoters
43.72%
Retail And Others
41.13%
Foreign Institutions
7.35%
Other Domestic Institutions
6.89%
Mutual Funds
0.90%

Mutual Funds Invested (3)

Fund name	AUM%
UTI Healthcare Fund Direct Growth	0.78
ICICI Prudential Children's Fund Direct Growth	0.36
HDFC Large and Mid Cap Fund Direct Growth	0.02

Similar stocks

Stock	Mkt price (1D)	52 week performance	Market cap	P/E ratio	P/B ratio
PfizerPFIZER	₹4,664.90 +20.30 (0.44%)	L H	21,235.87	29.39	5.05
Granules IndiaGRANULES	₹859.55 +5.75 (0.67%)	L H	21,173.01	31.97	4.49
Astrazeneca Pharma IndiaASTRAZEN	₹7,891.00 -140.00 (1.74%)	L H	20,082.63	107.09	23.01
Eris LifesciencesERIS	₹1,417.30 -23.30 (1.62%)	L H	19,961.54	30.82	5.11

ScoutQuest • 3 weeks ago

Aarti Pharmalabs opens new Tarapur block, adding 3,600 TPA capacity for Xanthine derivatives. Total capacity reaches 9,600 TPA, placing it among top 3 global Xanthine producers.

Moneycontrol • 1 month ago

Aarti Pharmalabs led gains amid a 385-point Sensex drop, Nifty below key levels. The stock displayed positive price action against broader market declines and sectoral flows.

economictimes.indiatimes.com • 1 month ago

Aarti Pharmalabs Ltd. mentioned in context of upcoming events and Q1 FY25 results.

ScoutQuest • 2 months ago

Aarti Pharmalabs targets 15-18% CAGR, Rs 400 Cr CapEx, and 40-50% CDMO growth by FY27.

ScoutQuest • 2 months ago

Aarti Pharmalabs' Q4 FY26 report highlights 220 products, 63 patents, and 7 USFDA-approved units. The company holds 15-20% global Xanthine market share, with Rs 65 Cr R&D spend and 2,400 employees.

NDTV Profit • 2 months ago

Experts analyze stocks including Hitachi Energy, Aarti Pharmalabs, Union Bank, and Balaji Amines, offering hold or buy advice based on technical and fundamental insights. Key recommendations include holding Tata Power, NTPC, and Coal India; buying HDFC Bank, Varun Beverages; and selling Indian Railway Finance Corp, Emmvee Photovoltaic Power.

Trade Brains • 2 months ago

Aarti Pharmalabs' Q4 profits dropped 31% despite stable revenues. The stock fell nearly 4% in early trade on May 26, 2026, post results.

Livesquawk • 2 months ago

Aarti Pharma's Q4 EBITDA dropped to ₹1.1B from ₹1.4B YoY. EBITDA margin decreased to 19.4% compared to 25.4% YoY.

BSE • 4 months ago

Promoter Mirik Rajendra Gogri disclosed pledging of 27,84,094 shares (3.08% of total share capital) of Aarti Pharmalabs Ltd. Shares were pledged on 25 Mar 2026 with Bajaj Financial Securities Ltd. and 360 One Distribution Services Ltd.

ScoutQuest • 4 months ago

Aarti Pharmalabs' Unit IV at Tarapur inspected by US FDA, ending 27-Mar-2026. One observation in Form 483 noted; corrective measures to be submitted on time.

2026

May

Quarterly & Annual Result

Release date

Check latest financial

May

Quarterly & Annual Result

Release date

Check latest financial

16
Feb
Dividend
Ex date
₹1.50
per share

For each share you hold, you will receive ₹1.50

Dividend amount₹1.50 per share

Dividend TypeInterim

Ex Date16 Feb ‘26

Record Date16 Feb ‘26

Announcement date9 Feb ‘26

9
Feb
Dividend
Announced
₹1.50
per share

For each share you hold, you will receive ₹1.50

Dividend amount₹1.50 per share

Dividend TypeInterim

Ex Date16 Feb ‘26

Record Date16 Feb ‘26

Announcement date9 Feb ‘26

Feb

Quarterly Result

Release date

Check latest financial

2025

Nov

Quarterly Result

Release date

Check latest financial

15
Sep
Dividend
Ex date
₹2.50
per share

For each share you hold, you will receive ₹2.50

Dividend amount₹2.50 per share

Dividend TypeFinal

Ex Date15 Sep ‘25

Record Date15 Sep ‘25

Announcement date10 May ‘25

Aug

Quarterly Result

Release date

Check latest financial

10
May
Dividend
Announced
₹2.50
per share

For each share you hold, you will receive ₹2.50

Dividend amount₹2.50 per share

Dividend TypeFinal

Ex Date15 Sep ‘25

Record Date15 Sep ‘25

Announcement date10 May ‘25

14
Feb
Dividend
Ex date
₹2.50
per share

For each share you hold, you will receive ₹2.50

Dividend amount₹2.50 per share

Dividend TypeInterim

Ex Date14 Feb ‘25

Record Date14 Feb ‘25

Announcement date5 Feb ‘25

5
Feb
Dividend
Announced
₹2.50
per share

For each share you hold, you will receive ₹2.50

Dividend amount₹2.50 per share

Dividend TypeInterim

Ex Date14 Feb ‘25

Record Date14 Feb ‘25

Announcement date5 Feb ‘25

2024

31
Jul
Dividend
Ex date
₹1.00
per share

For each share you hold, you will receive ₹1.00

Dividend amount₹1.00 per share

Dividend TypeFinal

Ex Date31 Jul ‘24

Record Date31 Jul ‘24

Announcement date13 May ‘24

Events calendar

View upcoming events in other stocks

Home>Stocks>Aarti Pharmalabs Ltd.

Vaishnavi Tech Park, South Tower, 3rd FloorSarjapur Main Road, Bellandur, Bengaluru – 560103Karnataka

Download the App

Share Market

Indices

F&O

Mutual Funds

ETFs

Funds By Groww

Calculators

IPO

Miscellaneous

NIFTY Bank Options SBI Options Bajaj Finance Options Axis Bank Options Hindustan Unilever Options NIFTY Bank Futures Finnifty Futures ITC Futures ICICI Bank Futures Biocon Futures Indusind Bank Futures Crude Oil Mini Future Price Gold Petal Future Price Silver Micro Future Price Nickel Future Price Natural Gas Mini MCX Option Chain Copper MCX Option Chain

NIFTY 50 Options HDFC Bank Options Wipro Options DLF Options REC Options Yes Bank Futures Zomato Futures Ashok Leyland Futures HDFC Bank Futures UPL Futures Adani Enterprises Futures Gold Future Price Natural Gas Future Price Zinc Future Price Gold MCX Option Chain Gold Mini MCX Option Chain Commodities Expiry Calendar

Bse Sensex Options Tata Steel Options NTPC Options Bajaj Auto Options Indusind Bank Options Tata Motors Futures Infosys Futures Asian Paints Futures Lupin Futures Cipla Futures IDFC First Bank Futures Gold Mini Future Price Natural Gas Mini Future Price Copper Future Price Crude Oil MCX Option Chain Silver MCX Option Chain

Finnifty Options Infosys Options Asian Paints Options Coal India Options Ashok Leyland Options Tata Steel Futures BSE Sensex Futures Wipro Futures DLF Futures Bajaj Finance Futures Piramal Enterprises Futures Gold Ten Future Price Silver Future Price Aluminium Future Price Crude Oil Mini MCX Option Chain Silver Mini MCX Option Chain

Tata Motors Options ITC Options ICICI Bank Options Adani Enterprises Options NIFTY 50 Futures Coal India Futures Axis Bank Futures Vedanta Futures Reliance Industries Futures Hindustan Copper Futures Crude Oil Future Price Gold Guinea Future Price Silver Mini Future Price Electricity Future Price Natural Gas MCX Option Chain Zinc MCX Option Chain

MF Screener Debt Mutual Funds Best Multicap Mutual funds Best Contra Mutual funds Best Conservative Hybrid Mutual funds SBI Contra Fund Nippon India Nifty 500 Momentum 50 Index Fund HDFC Balanced Advantage Fund Quant Mid Cap Fund Bank of India Small Cap Fund Quant Multi Asset Fund Nippon India TATA Bandhan Edelweiss HSBC Union Quantum Shriram

Compare Mutual Funds Best Debt Mutual funds Best Large Cap Mutual funds Best Value Oriented Mutual funds Parag Parikh Flexi Cap Fund HDFC Mid Cap Opportunities Fund Motilal Oswal Nifty India Defence Index Fund ICICI Prudential India Opportunities Fund Kotak Small Cap Fund Canara Robeco Bluechip Equity Fund GrowwMF Motilal Oswal Aditya Birla Axis Bank of India Bajaj Finserv Helios ITI Trust

MF Knowledge Centre Best Equity Mutual funds Best Small Cap Mutual funds Best Arbitrage Mutual funds Motilal Oswal Midcap Fund SBI Small Cap Fund HDFC Small Cap Fund Kotak Multicap Fund ICICI Prudential Infrastructure Fund Bandhan Nifty Alpha 50 Index Fund SBI Quant Mirae Asset DSP Baroda BNP Paribas Mahindra Manulife Sundaram Samco Taurus

Mutual Fund Houses Best Hybrid Mutual funds Best ELSS Mutual funds Best Dividend Yield Mutual funds Nippon India Small Cap Fund HDFC Flexi Cap Fund Tata Small Cap Fund Tata Ethical Fund Mirae Asset ELSS Tax Saver Fund Quant Infrastructure Fund HDFC PPFAS UTI Kotak Mahindra Zerodha Invesco Navi PGIM

Mutual Funds Categories Best MidCap Mutual funds Best Sectoral Mutual funds Best Aggressive Hybrid Mutual funds Quant Small Cap Fund SBI Magnum Children's Benefit Fund UTI Nifty 50 Index Fund JM Flexicap Fund HSBC Small Cap Fund Franklin India Multi Cap Fund ICICI Prudential LIC Canara Robeco Whiteoak Franklin Templeton NJ JM 360 One

International Silver Midcap Liquid

Debt Index Bank Nifty Nifty IT

Equity Nifty 50 Nifty Metal Nifty Auto

Commodity Nifty Next 50 Healthcare Groww

Gold Sensex Defence

What is IPO?How to Apply for an IPO

Open IPOs What is Grey Market Premium?

Upcoming IPOs Mainboard IPOs

Closed IPOs SME IPOs

IPO Subscription Status IPO Allotment Status

NFO Pricing Trust & Safety Groww Digest

Intraday Blog Investor Relations Invest in Gold

Corporate Bonds Media & Press Gold Rates Invest in Silver

HUF Demat Account Careers Silver Rates Sitemap

About Us Help & Support Glossary

Others:

NSEBSEMCXTerms and ConditionsPolicies and ProceduresRegulatory & Other InfoPrivacy PolicyDisclosureSMART ODRDownload FormsInformation Security PracticesInvestor Charter and GrievanceBug Bounty

Mutual Funds:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

Stocks:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

About Groww

Groww is India's largest Stock Broker with more than 1.4 crore active customers where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (CIN: U65100KA2016PTC092879) is a member of NSE & BSE & MCX with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - Vaishnavi Tech Park, South Tower, 3rd floor, Sarjapur Main Road, Bellandur, Bengaluru – 560103, Karnataka. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Investment in Securities Market are subject to market risks, read all the related documents carefully before investing

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

India's largest Stock Broker by active users on NSE as of June 30, 2025. Refer: NSE's Arbitration status

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.

Aarti Pharmalabs Ltd.

Performance

Fundamentals

Financial performance

About

Shareholding Pattern

Mutual Funds Invested (3)

Similar stocks

16FebDividendEx date₹1.50per share

9FebDividendAnnounced₹1.50per share

15SepDividendEx date₹2.50per share

10MayDividendAnnounced₹2.50per share

14FebDividendEx date₹2.50per share

5FebDividendAnnounced₹2.50per share

31JulDividendEx date₹1.00per share

About Groww

16
Feb
Dividend
Ex date
₹1.50
per share

9
Feb
Dividend
Announced
₹1.50
per share

15
Sep
Dividend
Ex date
₹2.50
per share

10
May
Dividend
Announced
₹2.50
per share

14
Feb
Dividend
Ex date
₹2.50
per share

5
Feb
Dividend
Announced
₹2.50
per share

31
Jul
Dividend
Ex date
₹1.00
per share